FDA issues warning on smart watches for blood sugar measurement
The agency stated that it has not authorized or approved these devices for measuring blood glucose levels independently.
Share:
The FDA has issued a warning about the risks associated with using certain smart watches to measure blood sugar levels.
The agency stated that it has not authorized or approved these devices for measuring blood glucose levels independently.
The FDA cautioned that using these unauthorized devices could result in inaccurate measurements and errors in diabetes management, which pose significant risks to individuals' health and could be life-threatening.
Users are advised to exercise caution and seek alternative methods for monitoring blood sugar levels until authorized devices are available.
